DrugPatentWatch Database Preview
Carvedilol - Generic Drug Details
What are the generic sources for carvedilol and what is the scope of carvedilol freedom to operate?
Carvedilol
is the generic ingredient in four branded drugs marketed by Apotex Inc, Aurobindo Pharma, Beximco Usa, Chartwell Molecular, Dr Reddys Labs Ltd, Glenmark Generics, Hikma, Lupin, Mylan, Pliva Hrvatska Doo, Sandoz, Sun Pharm Inds Inc, Sun Pharm Inds Ltd, Taro, Teva, Wockhardt Ltd, Zydus Pharms Usa Inc, Smithkline Beecham, Impax Labs Inc, and Sun Pharm Industries, and is included in twenty-one NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are thirty-six drug master file entries for carvedilol. Fifty-two suppliers are listed for this compound.
Summary for carvedilol
| US Patents: | 2 |
| Tradenames: | 4 |
| Applicants: | 20 |
| NDAs: | 21 |
| Drug Master File Entries: | 36 |
| Suppliers / Packagers: | 52 |
| Bulk Api Vendors: | 101 |
| Clinical Trials: | 131 |
| Patent Applications: | 6,431 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for carvedilol |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for carvedilol |
| DailyMed Link: | carvedilol at DailyMed |
Pharmacology for carvedilol
| Drug Class | alpha-Adrenergic Blocker beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic alpha-Antagonists Adrenergic beta1-Antagonists Adrenergic beta2-Antagonists |
Synonyms for carvedilol
| (+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol |
| (+-)-1-Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol |
| (+/-)-1-(Carbazol-4-yloxy)-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol |
| [3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine |
| 1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol |
| 1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol |
| 1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol |
| 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol |
| 1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol |
| 1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol |
| 102641-EP2270011A1 |
| 102641-EP2272841A1 |
| 102641-EP2275420A1 |
| 102641-EP2298764A1 |
| 102641-EP2298765A1 |
| 102641-EP2301936A1 |
| 107741-96-8 |
| 2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, (+-)- |
| 72956-09-3 |
| 956C093 |
| AB0008431 |
| AB00639903_10 |
| AB00639903_11 |
| AB00639903_12 |
| AB00639903-07 |
| AB00639903-09 |
| AB1004830 |
| AC-1641 |
| AC1L1E0B |
| AK163147 |
| AKOS005554967 |
| AN-14749 |
| API0001873 |
| Artist |
| Artist (TN) |
| Atlana Pharma brand of carvedilol |
| AX8120145 |
| BBL029064 |
| BC204100 |
| BCP0726000253 |
| BCP9000493 |
| BDBM25759 |
| BG0129 |
| Bio-0014 |
| BM 14,190 |
| BM 14.190 |
| BM 14190 |
| BM-14-190 |
| BM-14.190 |
| BM-14190 |
| BRD-A10977446-001-04-8 |
| BRD-A10977446-045-01-1 |
| C-21835 |
| C06875 |
| C24H26N2O4 |
| Carloc (TN) |
| Carvedilol (JAN/USAN/INN) |
| Carvedilol [USAN:INN:BAN:JAN] |
| Carvedilol [USAN:USP:INN:BAN:JAN] |
| Carvedilol 1.0 mg/ml in Methanol |
| Carvedilol for system suitability, European Pharmacopoeia (EP) Reference Standard |
| carvedilol HCl |
| Carvedilol hydrochloride |
| Carvedilol phosphate |
| carvedilol, (+-)-isomer |
| carvedilol, (R)-isomer |
| carvedilol, (S)-isomer |
| Carvedilol, >=98% (HPLC), solid |
| carvedilol, 14C-labeled |
| Carvedilol, European Pharmacopoeia (EP) Reference Standard |
| Carvedilol, pharmaceutical secondary standard; traceable to USP and PhEur |
| Carvedilol, United States Pharmacopeia (USP) Reference Standard |
| Carvedilolum |
| Carvedilolum [Latin] |
| carvediol |
| CC-25436 |
| CCG-100917 |
| CCG-207952 |
| CHEBI:3441 |
| CHEMBL723 |
| Coreg |
| Coreg (TN) |
| Coreg CR |
| Coropres |
| Coropress |
| CPD000449280 |
| CS-1194 |
| CTK3J2232 |
| D00255 |
| D0W9LX |
| DB01136 |
| Dibloc |
| Dilatrend |
| Dilatrend (TN) |
| DQ 2466 |
| DQ-2466 |
| DTXSID8022747 |
| EG-P042 |
| Eucardic |
| Eucardic (TN) |
| FT-0603059 |
| FT-0652640 |
| GlaxoSmithKline brand of carvedilol |
| GTPL551 |
| HMS2051N03 |
| HMS2089B09 |
| HMS2093E12 |
| HMS3261E15 |
| HMS3269N11 |
| HMS3393N03 |
| HMS3655O14 |
| HSDB 7044 |
| HY-B0006 |
| I06-0064 |
| I06-1477 |
| J10039 |
| KB-75594 |
| KBio2_002145 |
| KBio2_004713 |
| KBio2_007281 |
| KBio3_002323 |
| KBioGR_001252 |
| KBioSS_002145 |
| Kredex |
| KS-00000XRT |
| KS-1037 |
| KSC492E3F |
| L001243 |
| Lakeside brand of carvedilol |
| LP00347 |
| LS-121875 |
| MCULE-7944987271 |
| MFCD00864692 |
| MLS000758299 |
| MLS000759508 |
| MLS001424092 |
| MLS006011886 |
| MolPort-003-666-814 |
| NC00167 |
| NCGC00167832-01 |
| NCGC00167832-02 |
| NCGC00167832-03 |
| NCGC00167832-04 |
| NCGC00261032-01 |
| NSC-758694 |
| NSC758694 |
| OGHNVEJMJSYVRP-UHFFFAOYSA-N |
| Pharmakon1600-01504257 |
| PL008198 |
| PL039781 |
| PL068260 |
| PubChem18218 |
| Q-200801 |
| Querto |
| Roche brand of carvedilol |
| RTR-037608 |
| s1831 |
| SAM001246736 |
| SAM001247021 |
| SBI-0206771.P001 |
| SC-13445 |
| SCHEMBL10082334 |
| SCHEMBL13287211 |
| SCHEMBL22293 |
| SK&F-105517 |
| SKF 105517 |
| SMR000449280 |
| SPBio_001885 |
| Spectrum_001665 |
| Spectrum2_001673 |
| Spectrum3_001182 |
| Spectrum4_000636 |
| Spectrum5_001436 |
| SR-01000759289 |
| SR-01000759289-9 |
| ST24036957 |
| STK621453 |
| TL8005080 |
| Tox21_500347 |
| TR-037608 |
| W-5131 |
| Z2786051695 |
US Patents and Regulatory Information for carvedilol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | CARVEDILOL | carvedilol | TABLET;ORAL | 078332-002 | Sep 5, 2007 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Smithkline Beecham | COREG CR | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 022012-003 | Oct 20, 2006 | AB | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | Y | ➤ Try a Free Trial | ||
| Sandoz | CARVEDILOL | carvedilol | TABLET;ORAL | 078227-001 | Sep 5, 2007 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Impax Labs Inc | CARVEDILOL PHOSPHATE | carvedilol phosphate | CAPSULE, EXTENDED RELEASE;ORAL | 204717-004 | May 7, 2018 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-001 | Sep 14, 1995 | AB | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for carvedilol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-001 | Sep 14, 1995 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-004 | May 29, 1997 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-003 | Sep 14, 1995 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-002 | Sep 14, 1995 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Smithkline Beecham | COREG | carvedilol | TABLET;ORAL | 020297-003 | Sep 14, 1995 | ➤ Try a Free Trial | ➤ Try a Free Trial |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: